Heart Failure

Research presented this week at the European Society of Cardiology Congress in Munich suggests a new treatment may be emerging for transthyretin amyloid cardiomyopathy—a condition previously thought to be rare and untreatable.

Oregon’s only heart transplant program has suspended operations for at least two weeks after three cardiologists either left or announced plans to leave Oregon Health & Science University, The Oregonian reported Aug. 27.

Although heart failure researchers have made strides in enrolling more racial and ethnic minorities in clinical trials, women and older patients remain underrepresented, according to a systematic review published in JAMA Cardiology.

A new study in JAMA Cardiology uncovered a set of genetic variants that are almost exclusive to people of African ancestry and may explain their higher risk of adverse events related to dilated cardiomyopathy (DCM).

A clinical history of gout is associated with worse outcomes in patients with obstructive coronary artery disease (CAD), according to research published on Aug. 17 in the Journal of the American Heart Association.

The FDA on Aug. 17 sent a letter warning cardiologists about high mortality and stroke rates associated with the Temporary Total Artificial Heart (TAH-t) Companion 2 Driver System during a post-approval study.

Originally thought to be a benign condition, Takotsubo syndrome is associated with long-term outcomes similar to acute coronary syndrome (ACS), researchers reported in the Journal of the American College of Cardiology. And in cases where Takotsubo syndrome (TTS) is triggered by physical events, prognosis is even worse.

Estrogen may protect against heart failure (HF)-related depression by preventing the creation of inflammation-causing chemicals in the brain, according to research published in the American Journal of Physiology.

Japanese researchers believe they’ve identified a genetic risk marker that could pinpoint which people with atrial fibrillation (AFib) are at risk of developing tachycardia-induced cardiomyopathy.

Home-delivered sodium-restricted Dietary Approaches to Stop Hypertension (DASH/SRD) meals after heart failure (HF) hospitalizations appeared safe in some patients, has the potential to improve HF symptoms and can reduce readmissions, according to new research in Circulation: Heart Failure.

Shorter reperfusion times for patients with ST-segment elevation myocardial infarction (STEMI) are associated with fewer cases of in-hospital heart failure and fewer readmissions for heart failure over the next 30 days, according to an observational study from Singapore published in Circulation: Cardiovascular Quality and Outcomes.

Adult congenital heart disease (ACHD)-related heart failure (HF) hospitalizations have increased in recent years and are associated with disproportionately higher costs, procedural burden and health resource use, according to new research published in the Journal of the American Heart Association.